5 papers about lung cancer suggested by Stephen Liu

Stephen Liu, Head of Developmental Therapeutics at Georgetown Lombardi Comprehensive Cancer Center, shared a few must-reads papers on X:

A phase II study of tepotinib in patients with advanced solid cancers harboring MET exon 14 skipping mutations or amplification (KCSG AL19-17)

Authors: E.J. Kang, Y. Yang, S. Lee, Y.J. Kim, S.M. Lim, M.-J. Ahn, Y.J. Choi, Y. Lee, T.M. Kim, I. Kim, H.K. Ahn, H.-C. Jeung, S.I. Lee, S.Y. Oh, W.K. Bae, H. Ryu, K.H. Park, K.H. Lee

Advances and future directions in ROS1 fusion-positive lung cancer

Authors: Mary Boulanger, Jaime Schneider, Jessica Lin

Molecular profiling METex14+ non-small cell lung cancer (NSCLC): Impact of histology

Authors: Jennifer Marks, Nishant Gandhi, Balazs Halmos, Melina Marmarelis, So Yeon Kim, Lyudmila Bazhenova, Suresh Ramalingam, Joanne Xiu, Phillip Walker, Matthew Oberley, Patrick Mah, Stephen Liu

MET exon 14 skipping mutations in non-small-cell lung cancer: real-world data from the Italian biomarker ATLAS database

Authors: M.L. Reale et al.

M.L. RealeBrief Report: Targeted Therapies and Pancreatitis in Patients with Advanced Non-Small Cell Lung Cancer

Authors: May-Lucie Meyer, Louis Gros, Natalie Décosterd, Marco Tagliamento, Arianna Marinello, David Planchard, David Combarel, Fabrice Barlesi, Jordi Remon, Benjamin Besse, Mihaela Aldea

Follow Stephen Liu on X for more such content.

Stephen Liu is an Associate Professor of Medicine at Georgetown University, where he holds the positions of Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center.

As a board-certified medical oncologist specializing in lung cancer and drug development, Dr. Liu is known for his expertise in advanced thoracic malignancies. His research focuses on novel therapeutic agents and innovative combinations to improve treatment outcomes for patients with lung cancer.

Dr. Liu has received multiple teaching awards and actively engages in post-graduate education initiatives. Furthermore, he co-hosts the official podcast of the International Association for the Study of Lung Cancer (IASLC), “Lung Cancer Considered”.